Annual Shareholders Equity
$159.56 M
-$25.28 M-13.68%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual stockholders equity is $159.56 million, with the most recent change of -$25.28 million (-13.68%) on December 31, 2023.
- During the last 3 years, STOK annual shareholders equity has fallen by -$126.51 million (-44.22%).
- STOK annual shareholders equity is now -44.22% below its all-time high of $286.08 million, reached on December 31, 2020.
Performance
STOK Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$232.11 M
-$10.60 M-4.37%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly stockholders equity is $232.11 million, with the most recent change of -$10.60 million (-4.37%) on September 30, 2024.
- Over the past year, STOK quarterly shareholders equity has increased by +$59.11 million (+34.17%).
- STOK quarterly shareholders equity is now -18.86% below its all-time high of $286.08 million, reached on December 31, 2020.
Performance
STOK Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
STOK Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.7% | +34.2% |
| 3 y3 years | -44.2% | +34.2% |
| 5 y5 years | +51.9% | +34.2% |
STOK Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.7% | at low | -4.4% | +65.4% |
| 5 y | 5-year | -44.2% | at low | -18.9% | +65.4% |
| alltime | all time | -44.2% | >+9999.0% | -18.9% | +133.1% |
Stoke Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $232.11 M(-4.4%) |
| Jun 2024 | - | $242.71 M(+72.9%) |
| Mar 2024 | - | $140.34 M(-12.0%) |
| Dec 2023 | $159.56 M(-13.7%) | $159.56 M(-7.8%) |
| Sep 2023 | - | $173.00 M(-9.0%) |
| Jun 2023 | - | $190.19 M(-11.0%) |
| Mar 2023 | - | $213.82 M(+15.7%) |
| Dec 2022 | $184.85 M(-15.1%) | $184.85 M(-9.5%) |
| Sep 2022 | - | $204.14 M(-9.0%) |
| Jun 2022 | - | $224.32 M(-6.5%) |
| Mar 2022 | - | $239.98 M(+10.2%) |
| Dec 2021 | $217.78 M | $217.78 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $237.51 M(-6.9%) |
| Jun 2021 | - | $255.07 M(-6.4%) |
| Mar 2021 | - | $272.46 M(-4.8%) |
| Dec 2020 | $286.08 M(+27.5%) | $286.08 M(+48.6%) |
| Sep 2020 | - | $192.53 M(-5.3%) |
| Jun 2020 | - | $203.40 M(-5.1%) |
| Mar 2020 | - | $214.34 M(-4.5%) |
| Dec 2019 | $224.43 M(+113.6%) | $224.43 M(-4.0%) |
| Sep 2019 | - | $233.68 M(-3.3%) |
| Jun 2019 | - | $241.54 M(+142.6%) |
| Mar 2019 | - | $99.58 M(-5.2%) |
| Dec 2018 | $105.07 M(-8232.2%) | $105.07 M |
| Dec 2017 | -$1.29 M | - |
FAQ
- What is Stoke Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Stoke Therapeutics?
- What is Stoke Therapeutics annual shareholders equity year-on-year change?
- What is Stoke Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly shareholders equity year-on-year change?
What is Stoke Therapeutics annual stockholders equity?
The current annual shareholders equity of STOK is $159.56 M
What is the all time high annual shareholders equity for Stoke Therapeutics?
Stoke Therapeutics all-time high annual stockholders equity is $286.08 M
What is Stoke Therapeutics annual shareholders equity year-on-year change?
Over the past year, STOK annual stockholders equity has changed by -$25.28 M (-13.68%)
What is Stoke Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of STOK is $232.11 M
What is the all time high quarterly shareholders equity for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly stockholders equity is $286.08 M
What is Stoke Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, STOK quarterly stockholders equity has changed by +$59.11 M (+34.17%)